Pharmacotherapy of Diabetes: New Developments : Improving Life and Prognosis for Diabetic Patients

The treatment of Type 1 and Type 2 diabetes has changed radically over the past few years. Not only there are now new opportunities for treating the key abnormality in diabetes, increased blood glucose, by effective agents such as new insulin preparations and oral agents. A completely new concept has emerged, namely the multifactorial intervention strategy. It appears that it may be more important to treat elevated blood pressure, eventually marginally elevated, and dyslipidemia. New results have really proven to be decisive in changing the outcome of the patients. However, some uncertainties still exist which means that clear reviews are needed.

Summarizing all aspects of treatment, much work has been completed over the last few years within the treatment of complications in diabetes, nephropathy, retinopathy, neuropathy, and vascular medicine in general. This work provides an overview of all these new changes to be implemented in clinical practice.